Vail v. Juul Labs, Inc.

Cresco Labs Commends Ohioans on Legalizing Adult-Use Cannabis

Retrieved on: 
Wednesday, November 8, 2023

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today issued a statement on behalf of its CEO Charles Bachtell following over 56 percent of Ohioans voting to pass adult-use cannabis legalization through state ballot measure.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today issued a statement on behalf of its CEO Charles Bachtell following over 56 percent of Ohioans voting to pass adult-use cannabis legalization through state ballot measure.
  • Ohio represents the 24th state to end cannabis prohibition for adults 21 and over and the 15th state to legalize adult-use cannabis by election.
  • View the full release here: https://www.businesswire.com/news/home/20231107756443/en/
    Cresco Labs applauds cannabis legalization in Ohio.
  • Cresco Labs operates a 50,000 square foot cultivation and processing facility in Yellow Springs that distributes its industry-leading cannabis brands to approximately 60 percent of Ohio’s 111 operating medical dispensaries.

Cresco Labs Launches Good News Brand in Pennsylvania with New Sweet Troches

Retrieved on: 
Monday, October 9, 2023

Good News’ first product, Sweet Troches (troh-kees), is a sublingual form offered in six flavors with 10mg THC.

Key Points: 
  • Good News’ first product, Sweet Troches (troh-kees), is a sublingual form offered in six flavors with 10mg THC.
  • View the full release here: https://www.businesswire.com/news/home/20231009476659/en/
    Cresco Labs brings its Good News brand to Pennsylvania with the launch of Sweet Troches (Photo: Business Wire)
    “We’ve demonstrated repeatedly our ability to build our core brands and core products in new markets to meet market conditions, while also maintaining our strong number-one share positions,” said Charlie Bachtell, CEO & Co-founder of Cresco Labs.
  • We have many targeted strategies in place to continue to grow our share in the state, such as launching smart innovations like Sweet Troches from Good News.
  • In April, Cresco Labs introduced its first Troche from its Wonder Wellness Co. brand.

Cresco Labs Expands Sunnyside in Central Pennsylvania with New Store in Altoona

Retrieved on: 
Thursday, October 5, 2023

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of Sunnyside Altoona in the Commonwealth of Pennsylvania.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of Sunnyside Altoona in the Commonwealth of Pennsylvania.
  • View the full release here: https://www.businesswire.com/news/home/20231005449875/en/
    Cresco Labs opened a new Pennsylvania store in Altoona at 534 W Plank Rd.
  • (Photo: Business Wire)
    “We’re excited to expand in central Pennsylvania to meet the strong demand from patients and caregivers for top quality medical marijuana products,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.
  • Sunnyside Altoona is dedicated to helping qualified patients unlock all the benefits that medical marijuana can provide.

Cresco Labs Opens 33rd Florida Sunnyside in Jacksonville, 70th Store Nationwide

Retrieved on: 
Tuesday, September 12, 2023

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced the opening of a second Sunnyside in Jacksonville, Florida.
  • Today’s opening brings Cresco Labs’ store count to 33 dispensaries in Florida and 70 locations nationally.
  • View the full release here: https://www.businesswire.com/news/home/20230912928007/en/
    Cresco Labs opened a new Sunnyside dispensary at 2725 College St. in Jacksonville, Florida.
  • We’re bringing our bestselling branded products to our stores and expanding access to cannabis to more patients—it’s a win-win scenario,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.

Altria Seeks Importation Ban of JUUL E-Vapor Products; Files Patent Infringement Actions Against JUUL Labs

Retrieved on: 
Tuesday, August 22, 2023

Altria Group, Inc. (NYSE: MO) today announces that its subsidiary, NJOY, has filed a complaint against JUUL Labs, Inc. (JUUL) with the U.S. International Trade Commission (ITC).

Key Points: 
  • Altria Group, Inc. (NYSE: MO) today announces that its subsidiary, NJOY, has filed a complaint against JUUL Labs, Inc. (JUUL) with the U.S. International Trade Commission (ITC).
  • The complaint seeks a ban on the importation and sale of certain JUUL e-vapor products, including its currently marketed JUUL device and JUULpods.
  • “Protecting our intellectual property is critical to achieving our Vision,” said Murray Garnick, Executive Vice President and General Counsel.
  • NJOY acquired the Asserted Patents from Fuma International, LLC (Fuma) concurrently with the settlement of a patent infringement lawsuit filed against us by Fuma.

Chobani Strengthens Executive Leadership Team, Appointing Tom Cullen as Chief Information Officer

Retrieved on: 
Monday, July 24, 2023

NEW BERLIN, N.Y., July 24, 2023 /PRNewswire/ -- Chobani, the modern food company originally known for its Greek yogurt, has named Tom Cullen Chief Information Officer.

Key Points: 
  • NEW BERLIN, N.Y., July 24, 2023 /PRNewswire/ -- Chobani, the modern food company originally known for its Greek yogurt, has named Tom Cullen Chief Information Officer.
  • Cullen, who will report to Kevin Burns, President and Chief Operations Officer, will be responsible for the design and execution of best-in-class information systems and technological capabilities to fuel innovation and efficient operations ensuring Chobani has a competitive edge in the market.
  • Tom Cullen added: "I am excited to join Chobani, a mission-driven brand and company I have long admired.
  • Prior to joining Chobani, Cullen served as Chief Information Officer at Corsair, a leading global developer and manufacturer of high-performance gaming and streaming gear, where he played a critical role leading their digital technology transformation strategy and journey.

Commission Order Vacates ALJ Initial Decision and Dismisses Complaint in Case Against Altria and Juul

Retrieved on: 
Tuesday, July 4, 2023

In its order, the Commission also vacated the ALJ’s initial decision because the Commission’s dismissal deprived FTC staff attorneys of the ability they would otherwise have had to obtain review of the decision.

Key Points: 
  • In its order, the Commission also vacated the ALJ’s initial decision because the Commission’s dismissal deprived FTC staff attorneys of the ability they would otherwise have had to obtain review of the decision.
  • In doing so, the Commission clarified several matters of law that arose in the ALJ’s initial decision.
  • Vacating the ALJ’s initial decision means that it may no longer be cited as precedent.
  • An evidentiary hearing took place before the ALJ, who issued the initial decision recommending dismissal of the complaint, and FTC staff attorneys timely appealed.

Commission Order Vacates ALJ Initial Decision and Dismisses Complaint in Case Against Altria and Juul

Retrieved on: 
Tuesday, July 4, 2023

In its order, the Commission also vacated the ALJ’s initial decision because the Commission’s dismissal deprived FTC staff attorneys of the ability they would otherwise have had to obtain review of the decision.

Key Points: 
  • In its order, the Commission also vacated the ALJ’s initial decision because the Commission’s dismissal deprived FTC staff attorneys of the ability they would otherwise have had to obtain review of the decision.
  • In doing so, the Commission clarified several matters of law that arose in the ALJ’s initial decision.
  • Vacating the ALJ’s initial decision means that it may no longer be cited as precedent.
  • An evidentiary hearing took place before the ALJ, who issued the initial decision recommending dismissal of the complaint, and FTC staff attorneys timely appealed.

Cresco Labs Opens Sunnyside Destin and St. Petersburg Florida Stores, Expanding Nationwide Retail Footprint to 66 Locations

Retrieved on: 
Thursday, June 15, 2023

Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.

Key Points: 
  • Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No.
  • 1 producer of branded products, today announced it has expanded its Sunnyside brand in Florida with the opening of two new stores in Destin at 661 Harbor Blvd.
  • View the full release here: https://www.businesswire.com/news/home/20230615090774/en/
    Cresco Labs opened two new Florida stores in Destin and St. Petersburg.
  • Both Sunnyside Destin and Sunnyside St. Petersburg North will provide a wide assortment of accessories and products from the Company’s branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside.

Digital Pathology Market worth $1.8 billion | MarketsandMarkets

Retrieved on: 
Thursday, June 15, 2023

Based on type, the digital pathology market is segmented into human pathology and veterinary pathology.

Key Points: 
  • Based on type, the digital pathology market is segmented into human pathology and veterinary pathology.
  • The human pathology segment accounted for the largest share of 66.5% of digital pathology type market in 2022.
  • The growing awareness of early cancer diagnosis in emerging economies, and increasing collaborations among academic research institutes, universities, and pathology laboratories drives the growth of the human pathology segment in the digital pathology market.
  • UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS:
    Recent developments are important to understand the market trend and growth strategies adopted by players in the global digital pathology market space.